These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 11932281

  • 1. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA, Lewy V, Danadian K, Saad R.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [Abstract] [Full Text] [Related]

  • 2. The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome.
    Unlühizarci K, Keleştimur F, Sahin Y, Bayram F.
    Eur J Endocrinol; 1999 Jan; 140(1):56-61. PubMed ID: 10037253
    [Abstract] [Full Text] [Related]

  • 3. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K, Keleştimur F, Bayram F, Sahin Y, Tutuş A.
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 5. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E, Spina G, Kouli C, Migdalis I.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
    [Abstract] [Full Text] [Related]

  • 6. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):524-30. PubMed ID: 9024248
    [Abstract] [Full Text] [Related]

  • 7. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
    [Abstract] [Full Text] [Related]

  • 8. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
    Nestler JE, Jakubowicz DJ.
    N Engl J Med; 1996 Aug 29; 335(9):617-23. PubMed ID: 8687515
    [Abstract] [Full Text] [Related]

  • 9. Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.
    Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Apridonidze T, He N, Nestler JE.
    J Clin Endocrinol Metab; 2004 Jan 29; 89(1):242-9. PubMed ID: 14715857
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A.
    Eur J Endocrinol; 1998 Mar 29; 138(3):269-74. PubMed ID: 9539300
    [Abstract] [Full Text] [Related]

  • 11. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G, Steinberg HO, Shepard MK, Hook G, Baron AD.
    J Clin Endocrinol Metab; 2003 Feb 29; 88(2):576-80. PubMed ID: 12574183
    [Abstract] [Full Text] [Related]

  • 12. Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
    Guido M, Romualdi D, Suriano R, Giuliani M, Costantini B, Apa R, Lanzone A.
    Hum Reprod; 2004 Mar 29; 19(3):534-9. PubMed ID: 14998947
    [Abstract] [Full Text] [Related]

  • 13. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May 29; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 14. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.
    Arslanian SA, Lewy VD, Danadian K.
    J Clin Endocrinol Metab; 2001 Jan 29; 86(1):66-71. PubMed ID: 11231980
    [Abstract] [Full Text] [Related]

  • 15. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
    Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS.
    J Clin Endocrinol Metab; 1997 Jul 29; 82(7):2108-16. PubMed ID: 9215280
    [Abstract] [Full Text] [Related]

  • 16. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen HK, Tapanainen JS.
    J Clin Endocrinol Metab; 2000 Sep 29; 85(9):3161-8. PubMed ID: 10999803
    [Abstract] [Full Text] [Related]

  • 17. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D, De Cicco S, Tagliaferri V, Proto C, Lanzone A, Guido M.
    J Clin Endocrinol Metab; 2011 May 29; 96(5):E821-4. PubMed ID: 21307134
    [Abstract] [Full Text] [Related]

  • 18. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M, Yang M, Zhou X, Fang X, Hu W, Zhu W, Wang C, Liu D, Li S, Liu H, Yang G, Li L.
    J Clin Endocrinol Metab; 2015 Apr 29; 100(4):1485-93. PubMed ID: 25675380
    [Abstract] [Full Text] [Related]

  • 19. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
    Koivunen RM, Morin-Papunen LC, Ruokonen A, Tapanainen JS, Martikainen HK.
    Hum Reprod; 2001 Dec 29; 16(12):2546-51. PubMed ID: 11726572
    [Abstract] [Full Text] [Related]

  • 20. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
    Rittmaster RS, Deshwal N, Lehman L.
    J Clin Endocrinol Metab; 1993 May 29; 76(5):1295-300. PubMed ID: 8388405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.